intTypePromotion=3

Study protocol: Safety and efficacy of propranolol 0.2% eye drops in newborns with a precocious stage of retinopathy of prematurity (DROP-ROP-0.2%): A multicenter, open-label, single arm, phase II trial

Chia sẻ: ViDr2711 ViDr2711 | Ngày: | Loại File: PDF | Số trang:10

0
2
lượt xem
0
download

Study protocol: Safety and efficacy of propranolol 0.2% eye drops in newborns with a precocious stage of retinopathy of prematurity (DROP-ROP-0.2%): A multicenter, open-label, single arm, phase II trial

Mô tả tài liệu
  Download Vui lòng tải xuống để xem tài liệu đầy đủ

Retinopathy of prematurity (ROP) still represents one of the leading causes of visual impairment in childhood. Systemic propranolol has proven to be effective in reducing ROP progression in preterm newborns, although safety was not sufficiently guaranteed.

Chủ đề:
Lưu

Nội dung Text: Study protocol: Safety and efficacy of propranolol 0.2% eye drops in newborns with a precocious stage of retinopathy of prematurity (DROP-ROP-0.2%): A multicenter, open-label, single arm, phase II trial

ANTS
ANTS

CÓ THỂ BẠN MUỐN DOWNLOAD

 

Đồng bộ tài khoản